https://www.selleckchem.com/pr....oducts/belvarafenib.
e. Findings are limited by the observational design. Primary central nervous system lymphoma (PCNSL) requires induction and consolidation to achieve potential cure. High-dose therapy and autologous hematopoietic cell transplant (AHCT) is an accepted and effective consolidation strategy for PCNSL, but no consensus exists on the optimal conditioning regimens. To assess the outcomes in patients with PCNSL undergoing AHCT with the 3 most commonly used conditioning regimens thiotepa/busulfan/cyclophosphamide (TBC), thiotepa/carmustine (
Like
Comment
Share
